Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand?
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ramp up production enough. Source link
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ramp up production enough. Source link
A win would give Friedrich Merz the daunting task of rebuilding a German economy that hasn’t grown since 2019—and establish him as Europe’s main counterpart to Donald Trump. Source link